73
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy

&
Pages 4169-4180 | Published online: 24 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jiake Xu, Shaochun Li, Ye Feng, Jie Zhang, Youduo Peng, Xiaohong Wang & Hongwei Wang. (2022) The Fibrinogen/Albumin Ratio Index as an Independent Prognostic Biomarker for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgery. Cancer Management and Research 14, pages 1795-1806.
Read now

Articles from other publishers (2)

Ziwei Guo, Xing Wei, Chuanhao Tang & Jun Liang. (2024) Non-tumor-related prognostic factors for immunotherapy–chemotherapy or immunotherapy alone as first-line in advanced non-small cell lung cancer (NSCLC). Clinical and Experimental Medicine 24:1.
Crossref
Chang Hong, Han-Zhi Dong, Rui-Ning Li, Hong-Bo Zhu, Qi-Mei Li, Hao Cui, Cheng-Yi Hu, Chao-Yi Huang, Jie Peng, Li Liu, Xue-Jing Zou & Lu-Shan Xiao. (2023) Predictive Value of the Hepatic Immune Predictive Index for Patients with Primary Liver Cancer Treated with Immune Checkpoint Inhibitors. Digestive Diseases 41:3, pages 422-430.
Crossref